213 related articles for article (PubMed ID: 23580348)
21. Exploiting Honokiol-induced ER stress CHOP activation inhibits the growth and metastasis of melanoma by suppressing the MITF and β-catenin pathways.
Chiu CS; Tsai CH; Hsieh MS; Tsai SC; Jan YJ; Lin WY; Lai DW; Wu SM; Hsing HY; Arbiser JL; Sheu ML
Cancer Lett; 2019 Feb; 442():113-125. PubMed ID: 30391358
[TBL] [Abstract][Full Text] [Related]
22. Honokiol, a low molecular weight natural product, prevents inflammatory response and cartilage matrix degradation in human osteoarthritis chondrocytes.
Chen YJ; Tsai KS; Chan DC; Lan KC; Chen CF; Yang RS; Liu SH
J Orthop Res; 2014 Apr; 32(4):573-80. PubMed ID: 24375705
[TBL] [Abstract][Full Text] [Related]
23. Fibulin-5 inhibits Wnt/β-catenin signaling in lung cancer.
Chen X; Song X; Yue W; Chen D; Yu J; Yao Z; Zhang L
Oncotarget; 2015 Jun; 6(17):15022-34. PubMed ID: 25909283
[TBL] [Abstract][Full Text] [Related]
24. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
Nagalingam A; Arbiser JL; Bonner MY; Saxena NK; Sharma D
Breast Cancer Res; 2012 Feb; 14(1):R35. PubMed ID: 22353783
[TBL] [Abstract][Full Text] [Related]
25. TRIM27 acts as an oncogene and regulates cell proliferation and metastasis in non-small cell lung cancer through SIX3-β-catenin signaling.
Liu S; Tian Y; Zheng Y; Cheng Y; Zhang D; Jiang J; Li S
Aging (Albany NY); 2020 Dec; 12(24):25564-25580. PubMed ID: 33264103
[TBL] [Abstract][Full Text] [Related]
26. COXIBs and 2,5-dimethylcelecoxib counteract the hyperactivated Wnt/β-catenin pathway and COX-2/PGE2/EP4 signaling in glioblastoma cells.
Majchrzak-Celińska A; Misiorek JO; Kruhlenia N; Przybyl L; Kleszcz R; Rolle K; Krajka-Kuźniak V
BMC Cancer; 2021 May; 21(1):493. PubMed ID: 33941107
[TBL] [Abstract][Full Text] [Related]
27. Cleavage and polyadenylation specific factor 4 targets NF-κB/cyclooxygenase-2 signaling to promote lung cancer growth and progression.
Yi C; Wang Y; Zhang C; Xuan Y; Zhao S; Liu T; Li W; Liao Y; Feng X; Hao J; Gao Y; Yu W; Chen Y; Zhang C; Guo W; Tang B; Deng W
Cancer Lett; 2016 Oct; 381(1):1-13. PubMed ID: 27450326
[TBL] [Abstract][Full Text] [Related]
28. Neuroprotective effects of honokiol against beta-amyloid-induced neurotoxicity via GSK-3β and β-catenin signaling pathway in PC12 cells.
Xian YF; Ip SP; Mao QQ; Lin ZX
Neurochem Int; 2016 Jul; 97():8-14. PubMed ID: 27131736
[TBL] [Abstract][Full Text] [Related]
29. BCL9 promotes epithelial mesenchymal transition and invasion in cisplatin resistant NSCLC cells via β-catenin pathway.
Zhang Y; Zhang Q; Chen H; Wang C
Life Sci; 2018 Sep; 208():284-294. PubMed ID: 30009824
[TBL] [Abstract][Full Text] [Related]
30. Src Promotes Metastasis of Human Non-Small Cell Lung Cancer Cells through Fn14-Mediated NF-κB Signaling.
Wang W; Liu F; Wang C; Wang C; Tang Y; Jiang Z
Med Sci Monit; 2018 Mar; 24():1282-1294. PubMed ID: 29500337
[TBL] [Abstract][Full Text] [Related]
31. PTEN inactivation induces epithelial-mesenchymal transition and metastasis by intranuclear translocation of β-catenin and snail/slug in non-small cell lung carcinoma cells.
Perumal E; So Youn K; Sun S; Seung-Hyun J; Suji M; Jieying L; Yeun-Jun C
Lung Cancer; 2019 Apr; 130():25-34. PubMed ID: 30885348
[TBL] [Abstract][Full Text] [Related]
32. MiR-552-3p facilitated cell proliferation, migration and invasion by sponging Fibulin 5 in non-small cell lung cancer via activation of ERK/GSK3β/β-catenin signaling pathway.
Huang M; Liao X; Li L; Li G; Chen M
Tissue Cell; 2021 Dec; 73():101672. PubMed ID: 34736163
[TBL] [Abstract][Full Text] [Related]
33. Prostaglandin E2 promotes lung cancer cell migration via EP4-betaArrestin1-c-Src signalsome.
Kim JI; Lakshmikanthan V; Frilot N; Daaka Y
Mol Cancer Res; 2010 Apr; 8(4):569-77. PubMed ID: 20353998
[TBL] [Abstract][Full Text] [Related]
34. Cytological effects of honokiol treatment and its potential mechanism of action in non-small cell lung cancer.
Zhang J; Zhang Y; Shen W; Fu R; Ding Z; Zhen Y; Wan Y
Biomed Pharmacother; 2019 Sep; 117():109058. PubMed ID: 31176168
[TBL] [Abstract][Full Text] [Related]
35. Estrogen receptors promote NSCLC progression by modulating the membrane receptor signaling network: a systems biology perspective.
Gao X; Cai Y; Wang Z; He W; Cao S; Xu R; Chen H
J Transl Med; 2019 Sep; 17(1):308. PubMed ID: 31511014
[TBL] [Abstract][Full Text] [Related]
36. Honokiol suppresses TNF-α-induced migration and matrix metalloproteinase expression by blocking NF-κB activation via the ERK signaling pathway in rat aortic smooth muscle cells.
Zhu X; Wang Z; Hu C; Li Z; Hu J
Acta Histochem; 2014 May; 116(4):588-95. PubMed ID: 24360976
[TBL] [Abstract][Full Text] [Related]
37. Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates activation of cigarette smoke-induced nuclear factor (NF)-kappaB by suppressing activation of IkappaBalpha kinase in human non-small cell lung carcinoma: correlation with suppression of cyclin D1, COX-2, and matrix metalloproteinase-9.
Shishodia S; Aggarwal BB
Cancer Res; 2004 Jul; 64(14):5004-12. PubMed ID: 15256475
[TBL] [Abstract][Full Text] [Related]
38. NOVA1 promotes NSCLC proliferation and invasion by activating Wnt/β-catenin signaling.
Qu L; Tian Y; Wang F; Li Z
BMC Cancer; 2022 Oct; 22(1):1091. PubMed ID: 36284263
[TBL] [Abstract][Full Text] [Related]
39. Zbed3 promotes proliferation and invasion of lung cancer partly through regulating the function of Axin-Gsk3β complex.
Shi X; Zhao Y; Fan C
J Cell Mol Med; 2019 Feb; 23(2):1014-1021. PubMed ID: 30417576
[TBL] [Abstract][Full Text] [Related]
40. Synergistic killing effect of paclitaxel and honokiol in non-small cell lung cancer cells through paraptosis induction.
Li XQ; Ren J; Wang Y; Su JY; Zhu YM; Chen CG; Long WG; Jiang Q; Li J
Cell Oncol (Dordr); 2021 Feb; 44(1):135-150. PubMed ID: 32936421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
